Effect of antidiabetic drug on endothelial function

Trial Profile

Effect of antidiabetic drug on endothelial function

Phase of Trial: Phase II

Latest Information Update: 20 Mar 2018

At a glance

  • Drugs Linagliptin (Primary) ; Voglibose (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms EFFORT
  • Most Recent Events

    • 18 Mar 2018 Status changed from active, no longer recruiting to completed.
    • 20 Sep 2017 Status changed from recruiting to active, no longer recruiting.
    • 19 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top